| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/11/2004 | CN1519029A Biological preparation modified in plasma environment for treating AIDS and preparation method |
| 08/11/2004 | CN1519018A Combination of medicine for treating hepatitis |
| 08/11/2004 | CN1519008A Externally applied agent for relieving inflammation and antibiosis |
| 08/11/2004 | CN1519002A Extract product of Chinese traditional medicine as well as preparation method and application |
| 08/11/2004 | CN1519001A External lotion of Chinese traditional medicine for treating inflammation in female reproductive system |
| 08/11/2004 | CN1518994A Prescription of Chinese traditional medicine for relieving inflammation, detoxification and cancer prevention |
| 08/11/2004 | CN1518984A Preparation of non-intestinal tract administration Adefovir and Adefovir Dipivixi |
| 08/11/2004 | CN1518983A Coordinated modication combination for anti hepatitis B virus |
| 08/11/2004 | CN1518975A External use pharmaceutics in simple recipe and compound recipe for treating mycosis ungualis (tinea auguium, onychomycosis) |
| 08/11/2004 | CN1161460C Type-O hoof-and-mouth disease virus, type-O hoof-and-mouth disease vaccine with viurs and active component and prepn of the vaccine |
| 08/11/2004 | CN1161377C Giant web bombinator skin peptide and its prepn. and pharmaceutical application |
| 08/11/2004 | CN1161376C Major outer membrane protein CD of Moraxella |
| 08/11/2004 | CN1161374C Cyclopeptides of formulal |
| 08/11/2004 | CN1161360C Tetrazole-containg rapamycin analogs with shortened half-lives |
| 08/11/2004 | CN1161356C Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha' |
| 08/11/2004 | CN1161355C New compounds |
| 08/11/2004 | CN1161352C Quinazoline derivatives |
| 08/11/2004 | CN1161336C Quinolinecarboxamides as antiviral agents |
| 08/11/2004 | CN1161138C Tonic medicine for phthisis patient and its prepn |
| 08/11/2004 | CN1161125C Blood-type grasserie preventing and treating medicine for silkworm and its prepn |
| 08/11/2004 | CN1161116C Use of L-Carnitine and derviatives for reducing ceramide levels and potentiating antiretroviral |
| 08/11/2004 | CN1161113C Methods for treatment of neuro-and nephro-disorders and therapeutic toxicities using aminothiol compounds |
| 08/11/2004 | CN1161107C Oral formulation for gastrointestinal drug delivery |
| 08/11/2004 | CN1161021C Method of biological control |
| 08/10/2004 | US6774231 Bactericides |
| 08/10/2004 | US6774229 Coupling condensation synthesis of heterocycles |
| 08/10/2004 | US6774220 Compounds having lectinic properties and their biological applications |
| 08/10/2004 | US6774212 For therapy of viral infection or as an assay standard or reagent |
| 08/10/2004 | US6774134 For therapy of respiratory syncytial virus infection |
| 08/10/2004 | US6774132 Spirooxindole derivatives that act as analgesics |
| 08/10/2004 | US6774127 Pyrazole and pyrazoline substituted compounds |
| 08/10/2004 | US6774104 Cyclic polypeptide stabilized with lactose |
| 08/10/2004 | US6774102 Extracorporeal endotoxin removal method |
| 08/10/2004 | US6773916 Administering sub-immunological sized antigen-binding molecule (fc/fv fragments) |
| 08/10/2004 | US6773915 Detecting antibodies; culture product |
| 08/10/2004 | US6773912 Lantibiotic |
| 08/10/2004 | US6773908 From open reading frames; vaccines |
| 08/10/2004 | US6773880 Bactericides; vaccine development; infection diagnosis; |
| 08/10/2004 | US6773716 Over-coated chewing gum formulations |
| 08/10/2004 | US6773710 Recombinant canine distemper virus vaccine against canine distemper and leishmaniasis |
| 08/10/2004 | US6773709 Chicken embryo lethal (CELO) virus |
| 08/10/2004 | US6773708 Suppression of excessive th1 and stimulation of th2 cell mediated immune responses |
| 08/10/2004 | US6773706 Enzymatic polypeptide for use in the diagnosis and treatment of bacterial infections |
| 08/10/2004 | US6773701 Expression enhancer for protein synthesis inhibitory genes |
| 08/10/2004 | CA2457651A1 Antibodies for discrimination of prions |
| 08/10/2004 | CA2293011C Process for the preparation of n-(amino-4,6-dihalopyrimidine)formamides |
| 08/10/2004 | CA2187024C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 08/10/2004 | CA2129101C Synthetic haemophilus influenzae conjugate vaccine |
| 08/10/2004 | CA2124999C Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
| 08/10/2004 | CA2092094C Dextrin sulfates as anti-hiv-1 agents and composition thereof |
| 08/09/2004 | CA2538147A1 Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical |
| 08/05/2004 | WO2004065607A1 Novel physiologically active substance rs-k3574 and process for producing the same |
| 08/05/2004 | WO2004065601A2 Lipophilic derivatives of double-stranded ribonucleic acid |
| 08/05/2004 | WO2004065413A1 Novel substances k01-b0171 and process for producing the same |
| 08/05/2004 | WO2004065406A2 Rantes-derived peptides with anti-hiv activity |
| 08/05/2004 | WO2004065401A1 Polyene polyketides, processes for their production and their use as a pharmaceutical |
| 08/05/2004 | WO2004065400A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 08/05/2004 | WO2004065367A1 Viral polymerase inhibitors |
| 08/05/2004 | WO2004064925A1 Viral polymerase inhibitors |
| 08/05/2004 | WO2004064912A1 An otorhinological delivery device |
| 08/05/2004 | WO2004064850A1 Antiviral composition comprising a sulphated glucose polymer and a bacteriostatic agent |
| 08/05/2004 | WO2004064849A1 Means for normalising structure and functions of organs and tissues, stimulating injury recovery and exhibiting antiviral activity |
| 08/05/2004 | WO2004064837A1 Antibacterial fab i inhibitors |
| 08/05/2004 | WO2004064742A2 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 08/05/2004 | WO2004064732A2 The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl |
| 08/05/2004 | WO2004064715A2 Polyhydroxylated pyrrolizidine |
| 08/05/2004 | WO2004043996A3 Ligands |
| 08/05/2004 | WO2004029192A3 Producing method of tien hsien liquid |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004021969A3 Non-nucleoside reverse transcriptase inhibitors |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2004000226A3 Liposomes containing biologically active compounds |
| 08/05/2004 | WO2003103590A3 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/05/2004 | WO2003086319A3 Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant |
| 08/05/2004 | WO2003068142A3 1,2,4-triazol-1-yl-propan-2-ol derivatives as anti-fungal agents |
| 08/05/2004 | WO2003057830A3 Compositions and methods for hydroxylating epothilones |
| 08/05/2004 | WO2003048383A3 Effectors of innate immunity |
| 08/05/2004 | US20040152906 Sulfonamides |
| 08/05/2004 | US20040152893 Sulfonamides |
| 08/05/2004 | US20040152891 Sulfonamides |
| 08/05/2004 | US20040152772 1-butyric acid derivatives and the use thereof |
| 08/05/2004 | US20040152762 Oxidation resistance; from hesperidin using Aspergillus fermentation |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152753 Methods of use for novel sulfur containing organic nitrate compounds |
| 08/05/2004 | US20040152752 Administering cyclooxygenase inhibitor; topical administering |
| 08/05/2004 | US20040152751 Viricides; suppress lymphocytes; aids therapy; antiinflammatory agents |
| 08/05/2004 | US20040152726 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 08/05/2004 | US20040152723 Pharmaceutical compositions and methods for use |
| 08/05/2004 | US20040152714 Benzylaminopyrimidines |
| 08/05/2004 | US20040152674 Pharmaceutically active compounds and methods of use thereof |
| 08/05/2004 | US20040152669 Anti-bacterial agents based upon oxoanion binding |
| 08/05/2004 | US20040152661 Methods and compositions for treating viral diseases |
| 08/05/2004 | US20040152653 Administering a pharmacologic complex to the airway epithelium via its luminal surface, wherein the complex comprises a ligand for serpin enzyme complex receptor (SecR) and a pharmacologic agent |
| 08/05/2004 | US20040152652 Therapy of inflammatory disorder in an individual comprising administering oligonucleotide up to 30 nucleotides in length complementary to a nucleic acid molecule encoding human tumor necrosis factor- alpha |
| 08/05/2004 | US20040152625 Administering 5,11-Dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one and one or more inhibitors of CYP 450 for therapy of HIV |
| 08/05/2004 | US20040152191 Using activator glycoprotein to propagate activated macrophages or dendritic cells from monocytes or hematopoietic stem cells for use in treatment of allergic, cell proliferative, autoimmune and infectious disorders |
| 08/05/2004 | US20040152182 Viral particles released after infection by human cytomegalovirus, and their use as vaccine |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152156 Nucleotide sequences coding counter-ligands for several receptors expressed on lymphocytes for use in diagnosis and treatment of asthma, allergic or inflammatory disease |